相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Awareness of various aspects of diabetes among people visiting tertiary eye care institute in north India
Shikha Sharma et al.
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2020)
Biodegradable polymers in gene-silencing technology
Hossein Hosseinkhani et al.
POLYMERS FOR ADVANCED TECHNOLOGIES (2019)
Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience
Paulo Mello Filho et al.
OPHTHALMOLOGICA (2019)
Intravitreal dexamethasone implant Ozurdex® in naive and refractory patients with different subtypes of diabetic macular edema
Veronica Castro-Navarro et al.
BMC OPHTHALMOLOGY (2019)
A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion
Francesco Bandello et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2018)
Overview on natural hydrophilic polysaccharide polymers in drug delivery
Fatemeh Abedini et al.
POLYMERS FOR ADVANCED TECHNOLOGIES (2018)
Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B)
Lars-Olof Hattenbach et al.
ACTA OPHTHALMOLOGICA (2018)
A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
David G. Callanan et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the RANIDEX study
Irini Chatziralli et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines
Taraprasad Das et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2016)
Silk fibroin nanoparticle as a novel drug delivery system
Fatemeh Mottaghitalab et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema
Hemal Mehta et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2015)
A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema The BEVORDEX Study
Mark C. Gillies et al.
OPHTHALMOLOGY (2014)
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
David S. Boyer et al.
OPHTHALMOLOGY (2014)
Misclassification Can Explain Most Apparent Regression of Age-Related Macular Degeneration: Results From Multistate Models With Misclassification
Ronald E. Gangnon et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials RISE and RIDE
David M. Brown et al.
OPHTHALMOLOGY (2013)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W. Y. Yau et al.
DIABETES CARE (2012)
The RESTORE Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema
Paul Mitchell et al.
OPHTHALMOLOGY (2011)
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Pascale Massin et al.
DIABETES CARE (2010)
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Xinzhi Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2010)
Etiology and Treatment of Macular Edema
Mark W. Johnson
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Duration of action of intravitreal ranibizumab and bevacizumab in exudative AMD eyes based on macular volume measurements
A. R. Shah et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)